Intelligent, Aggressive Representation For The Injured And Disabled

Attorneys Gardberg & Kemmerly
Photo of attorneys Jonathan P. Gardberg and Colin Edward Kemmerly


Xarelto is a blood thinner manufactured by Janssen Pharmaceutical, a Johnson & Johnson subsidiary. In 2011, Xarelto was approved by the U.S. Food and Drug Administration to prevent blood clots for those suffering from atrial fibrillation, deep vein thrombosis, pulmonary embolism, stroke, or knee/ hip replacement surgery. Xarelto has been found to cause death due to severe internal bleeding. Other side effects of Xarelto include intestinal bleeding, rectal bleeding, and brain hemorrhaging. The Food and Drug Administration issued a black box warning against Xarelto indicating that the drug carried a significant risk of serious or life-threatening side effects.

A lawsuit has been filed against Janssen Pharmaceutical and the co-marketer of Xarelto, Bayer Healthcare alleging that the companies failed to warn patients and physicians of the increased risk of internal bleeding when using Xarelto. The lawsuit also alleges that Xarelto was not thoroughly tested before it was put on the market. The Xarelto blood thinner litigation has been consolidated before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana. Recently, a $650 million settlement was reached with the manufacturers of Pradaxa, a blood thinning medication similar to Xarelto.

If you or a loved one has been injured by Xarelto or has died following Xarelto use, you may have a personal injury claim. Contact an experienced personal injury attorney at Gardberg & Kemmerly, P.C. at 251-343-1111. An experienced personal injury attorney can provide you with a consultation, protect your rights, and guide you through the legal process.



RSS Feed